Boston Trust Walden Corp Charles River Laboratories International, Inc. Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

A detailed history of Boston Trust Walden Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 196,145 shares of CRL stock, worth $38.8 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

196,145

Previous 200,314 2.08%

Holding current value

$38.8 Million

Previous $41.4 Million 6.63%

% of portfolio

0.27%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$187.96 - $245.29 $783,605 - $1.02 Million	-4,169 Reduced 2.08%	196,145 $38.6 Million
Q2 2024 Jul 19, 2024	BUY	$206.39 - $268.73 $1.11 Million - $1.44 Million	5,375 Added 2.76%	200,314 $41.4 Million
Q1 2024 Apr 22, 2024	SELL	$203.52 - $273.43 $492,518 - $661,700	-2,420 Reduced 1.23%	194,939 $52.8 Million
Q4 2023 Jan 24, 2024	BUY	$164.52 - $238.84 $1.06 Million - $1.54 Million	6,462 Added 3.39%	197,359 $46.7 Million
Q3 2023 Oct 18, 2023	BUY	$194.44 - $217.61 $168,968 - $189,103	869 Added 0.46%	190,897 $37.4 Million
Q2 2023 Jul 24, 2023	BUY	$183.71 - $210.25 $2.89 Million - $3.31 Million	15,746 Added 9.03%	190,028 $40 Million
Q1 2023 Apr 19, 2023	BUY	$191.89 - $259.92 $6.47 Million - $8.76 Million	33,693 Added 23.97%	174,282 $35.2 Million
Q4 2022 Jan 20, 2023	BUY	$197.11 - $250.07 $7.95 Million - $10.1 Million	40,316 Added 40.21%	140,589 $0
Q3 2022 Oct 19, 2022	SELL	$182.44 - $250.54 $153,249 - $210,453	-840 Reduced 0.83%	100,273 $19.7 Million
Q2 2022 Jul 22, 2022	BUY	$204.13 - $302.4 $451,331 - $668,606	2,211 Added 2.24%	101,113 $21.6 Million
Q1 2022 Apr 20, 2022	BUY	$255.51 - $362.11 $3.69 Million - $5.23 Million	14,431 Added 17.08%	98,902 $28.1 Million
Q4 2021 Jan 21, 2022	BUY	$351.38 - $448.68 $298,321 - $380,929	849 Added 1.02%	84,471 $31.8 Million
Q3 2021 Oct 25, 2021	SELL	$372.64 - $458.3 $767,265 - $943,639	-2,059 Reduced 2.4%	83,622 $34.5 Million
Q2 2021 Jul 22, 2021	BUY	$294.17 - $371.65 $2.91 Million - $3.68 Million	9,899 Added 13.06%	85,681 $31.7 Million
Q1 2021 Apr 21, 2021	BUY	$249.67 - $299.48 $2.71 Million - $3.25 Million	10,839 Added 16.69%	75,782 $22 Million
Q4 2020 Jan 15, 2021	BUY	$222.0 - $252.62 $400,488 - $455,726	1,804 Added 2.86%	64,943 $16.2 Million
Q3 2020 Oct 14, 2020	BUY	$175.56 - $226.45 $173,628 - $223,959	989 Added 1.59%	63,139 $14.3 Million
Q2 2020 Jul 23, 2020	SELL	$118.84 - $189.72 $5.02 Million - $8.01 Million	-42,207 Reduced 40.44%	62,150 $10.8 Million
Q1 2020 Apr 24, 2020	SELL	$98.9 - $178.34 $2.48 Million - $4.47 Million	-25,085 Reduced 19.38%	104,357 $13.2 Million
Q1 2020 Apr 21, 2020	SELL	$98.9 - $178.34 $1.69 Million - $3.05 Million	-17,100 Reduced 11.67%	129,442 $16.3 Million
Q4 2019 Jan 10, 2020	BUY	$126.05 - $152.76 $225,755 - $273,593	1,791 Added 1.24%	146,542 $22.4 Million
Q3 2019 Oct 21, 2019	BUY	$125.07 - $143.67 $186,479 - $214,211	1,491 Added 1.04%	144,751 $19.2 Million
Q2 2019 Jul 25, 2019	SELL	$123.4 - $148.55 $182,632 - $219,854	-1,480 Reduced 1.02%	143,260 $20.3 Million
Q1 2019 Apr 16, 2019	BUY	$104.82 - $146.73 $268,653 - $376,068	2,563 Added 1.8%	144,740 $21 Million
Q4 2018 Jan 17, 2019	SELL	$105.09 - $137.23 $749,922 - $979,273	-7,136 Reduced 4.78%	142,177 $16.1 Million
Q3 2018 Oct 23, 2018	SELL	$112.11 - $134.54 $651,807 - $782,215	-5,814 Reduced 3.75%	149,313 $20.1 Million
Q2 2018 Jul 25, 2018	BUY	$102.37 - $117.25 $4.21 Million - $4.82 Million	41,134 Added 36.08%	155,127 $17.4 Million
Q1 2018 Apr 13, 2018	SELL	$98.19 - $115.2 $838,837 - $984,153	-8,543 Reduced 6.97%	113,993 $12.2 Million
Q4 2017 Jan 29, 2018	BUY	$100.43 - $118.09 $12.3 Million - $14.5 Million	122,536	122,536 $13.4 Million

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Charles River Laboratories International, Inc. Transaction History